Results 341 to 350 of about 531,871 (379)
Some of the next articles are maybe not open access.
Thoracic Surgery Clinics, 2020
Five-year survival rates for patients with early-stage non-small cell lung cancer have room for improvement. Adjuvant chemotherapy results in a small but significant increase in overall survival at 5 years. Efforts to improve outcomes by intensifying adjuvant treatment, utilizing cancer-specific vaccines or tyrosine kinase inhibitors in unselected ...
Jessica A, Hellyer, Heather A, Wakelee
openaire +2 more sources
Five-year survival rates for patients with early-stage non-small cell lung cancer have room for improvement. Adjuvant chemotherapy results in a small but significant increase in overall survival at 5 years. Efforts to improve outcomes by intensifying adjuvant treatment, utilizing cancer-specific vaccines or tyrosine kinase inhibitors in unselected ...
Jessica A, Hellyer, Heather A, Wakelee
openaire +2 more sources
2018
Developing new vaccines against emerging pathogens or pathogens where variability of antigenic sites presents a challenge, the inclusion of stimulators of the innate immune system is critical to mature the immune response in a way that allows high avidity recognition while preserving the ability to react to drifted serovars. The innate immune system is
Darrick, Carter +2 more
openaire +3 more sources
Developing new vaccines against emerging pathogens or pathogens where variability of antigenic sites presents a challenge, the inclusion of stimulators of the innate immune system is critical to mature the immune response in a way that allows high avidity recognition while preserving the ability to react to drifted serovars. The innate immune system is
Darrick, Carter +2 more
openaire +3 more sources
Current HIV Research, 2010
The vast majority of pathogens invade the body through or establish infections in the mucosal tissues. Development of vaccines to combat mucosal infections represents a top priority. Mucosal immunization has recently attracted much interest as a means of generating protective immunity against mucosal pathogens.
HARANDI A. M., MEDAGLINI D.
openaire +4 more sources
The vast majority of pathogens invade the body through or establish infections in the mucosal tissues. Development of vaccines to combat mucosal infections represents a top priority. Mucosal immunization has recently attracted much interest as a means of generating protective immunity against mucosal pathogens.
HARANDI A. M., MEDAGLINI D.
openaire +4 more sources
Visceral Leishmaniasis, 2021
Results: The Alliance has developed a unique formulation solution combining foam properties and reduced interfacial tension, even in high temperature and harsh conditions of injection brine.
Awanish Kumar
openaire +2 more sources
Results: The Alliance has developed a unique formulation solution combining foam properties and reduced interfacial tension, even in high temperature and harsh conditions of injection brine.
Awanish Kumar
openaire +2 more sources
2009
This chapter focuses on the therapeutic strategies for patients with gliomas other than surgery (Chap. 6) and radiotherapy (Chap. 7). It deals with gliomas of all WHO grades and details the primary treatment as well as therapeutic options at recurrence.
Wick, W, Weller, M
openaire +2 more sources
This chapter focuses on the therapeutic strategies for patients with gliomas other than surgery (Chap. 6) and radiotherapy (Chap. 7). It deals with gliomas of all WHO grades and details the primary treatment as well as therapeutic options at recurrence.
Wick, W, Weller, M
openaire +2 more sources
Veterinary Immunology and Immunopathology, 1987
A number of adjuvants of importance in veterinary vaccines are reviewed. These include mineral salt adjuvants, oil adjuvants, hydrophilic and hydrophobic bloc polymers, hydrocarbons and surface active agents. The current and future applications of these substances and their possible modes of action are discussed. Creation of an adjuvant register by the
openaire +2 more sources
A number of adjuvants of importance in veterinary vaccines are reviewed. These include mineral salt adjuvants, oil adjuvants, hydrophilic and hydrophobic bloc polymers, hydrocarbons and surface active agents. The current and future applications of these substances and their possible modes of action are discussed. Creation of an adjuvant register by the
openaire +2 more sources
Medical Clinics of North America, 2007
Adjuvant analgesics represent a diverse group of drugs that were originally developed for a primary indication other than pain. Many of these medications are currently used to enhance analgesia under specific circumstances. The proper use of adjuvant drugs is one of the keys to success in effective pain management.
Helena, Knotkova, Marco, Pappagallo
openaire +3 more sources
Adjuvant analgesics represent a diverse group of drugs that were originally developed for a primary indication other than pain. Many of these medications are currently used to enhance analgesia under specific circumstances. The proper use of adjuvant drugs is one of the keys to success in effective pain management.
Helena, Knotkova, Marco, Pappagallo
openaire +3 more sources
Adjuvant castration versus adjuvant chemotherapy
International Journal of Radiation Oncology*Biology*Physics, 1978Furthermore, in premenopausal women under 45 years of age Meakin et al.” failed to observe a significant difference in terms of delay of recurrence and prolongation of survival between those who had radical mastectomy (RM) and RM plus ovarian irradiation (RT). Since histologically positive axillary lymph nodes were identified in 87% (RM) and in 98% (RT)
openaire +2 more sources
Clinical Infectious Diseases, 1980
Nonreplicating, purified subunit or synthetic viral vaccines of the future are likely to be weak immunogens that will require immunopotentiation if they are to be effective. These marginal vaccines could be improved by combination with potent and safe immunologic adjuvants. The use of adjuvants should also reduce the amount of purified antigen required
openaire +2 more sources
Nonreplicating, purified subunit or synthetic viral vaccines of the future are likely to be weak immunogens that will require immunopotentiation if they are to be effective. These marginal vaccines could be improved by combination with potent and safe immunologic adjuvants. The use of adjuvants should also reduce the amount of purified antigen required
openaire +2 more sources
Adjuvant activity of incomplete Freund's adjuvant
Advanced Drug Delivery Reviews, 1998The water-in-oil emulsion adjuvants developed by Jules Freund and coworkers have been, and continue to be, used in research and veterinary vaccines. Incomplete Freund's Adjuvant (IFA) has also been widely tested in humans where it was shown to augment antibody responses greater than other adjuvants, such as alum, and to be well tolerated.
, Jensen, , Savary, , Diveley, , Chang
openaire +2 more sources